With Mandatory Product Listing, FDA Not Looking For Gate To Open Or Close On Supplements

Mandatory product listings would help FDA eliminate gap of missing NDI notifications it expects haven't been filed and other information about ingredients but not establish pre-market approval tool.

• Source: Shutterstock

The Food and Drug Administration doesn’t intend for a potential mandatory product listing requirement for dietary supplements to a barrier to additional products reaching the US market, says Office of Dietary Supplements Program director Cara Welch.

More from Regulation

More from Policy & Regulation